Session Description:
Type 2 Diabetes in kidney disease: best practices for detection, treatment and recent updates on findings from clinical trials.
Learning objectives:
1.Provide an overview of best practices for detection and treatment for people living with kidney disease with Type 2 diabetes.
2.Sharing new and powerful treatment and discussions on findings from clinical trials about new effective treatment.
| Time | Session |
|---|
|
9 a.m.
9:06 a.m.
|
Setting the Scene
MegJardine
Speaker
meg.jardine@sydney.edu.auNHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia
|
|
9:06 a.m.
9:21 a.m.
|
DM and CKD: Which Treatment Should I Use for Different Populations?
KatherineTuttle
Speaker
Katherine.Tuttle@providence.orgUniversity of Washington School of Medicine, Division of NephrologyUnited States
|
|
9:21 a.m.
9:36 a.m.
|
How to Design Studies on Answering Unanswered Questions
VladoPerkovic
Speaker
vlado.perkovic@unsw.edu.auUniversity of New South Wales, Sydney, AustraliaAustralia
|
|
9:36 a.m.
9:51 a.m.
|
The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes
|
|
9:51 a.m.
10 a.m.
|
Q and A
|